Abstract:
The invention disclosed is a sealed fluent material container (10) having a chamber (22) with an opening (28) provided with a manually operable primary closure mechanism (36) and a secondary closure mechanism (70) that may be operated either manually or automatically. Manual removal of the primary closure mechanism (36) from the chamber opening allows the secondary closure mechanism (70) to extend a laterally moveable tongue (70) from a horizontal guide recess (80) on the top of the container (10) to a normally closed position covering the opening (28). An engageable tab (74) on the secondary closure (70) permits the retraction of the moveable tongue (70) against the biasing means (84) to expose the chamber opening. The container (10) has particular utility for use in automated chemical dispensers, analyzers and related equipment for the analysis and testing of blood, physiological fluids and other biological samples.
Abstract:
An improved optical system for use in an instrument for culturing and detecting the presence of microorganisms in human tissue specimens is disclosed. The improved optical detection system is designed to reduce unwanted noise by substantially blocking all light other than light from a sensor positioned on an inside wall of a culture bottle from reaching the photodetector. A control circuit providing a "lock-in" detection system designed to reduce unwanted noise is also disclosed. The detection system is capable of rapidly and automatically detecting whether a specimen bottle has been inserted into the instrument.
Abstract:
In accordance with the present invention, there is provided a recombinant rabbit heavy chain variable domain, or single domain antibody having the ability to bind to a solid phase, for example, plastic, without a decrease in antigen capture capacity. The present invention further provides an improved immunological sandwich assay, such as an ELISA, in which the rabbit single domain antibody of the present invention is directly bound to the solid phase as the capture antibody. The resulting assay is less complex than systems currently utilized without any decrease in sensitivity.
Abstract:
This invention is directed to a multi-test immunochemical reagent and method to use the same in radial partition immunoassays. More particularly, this invention relates to a human immunochemical reagent having antiserum to a specific animal species adsorbed on to an inert porous medium.
Abstract:
The present invention relates to a serological method for detection of antibodies to HTLV-II in a blood sample using a synthetic peptide coated on a solid phase consisting of the amino acids of Sequence Id. Nos. 1-7. Additionally, this invention relates to a diagnostic test kit for the detection of HTLV-II.
Abstract:
This invention relates to a method for measuring the fibrinolytic capacity of whole plasma. This method comprises coating a solid support with a plasminogen binding material such as polylysine, fibrinogen or fibrin, adding a plasma sample or control and then measuring the amount of plasmin bound to the support. This method is particularly advantageous as the immobilized plasminogen binding material provides a surface which mimics the in vivo surface of a fibrin clot.
Abstract:
An assay for detection of serum antibodies having specificity to hepatitis C viral antigens utilizes the carboxy-terminal 102 amino acids of the c33c region of nonstructural gene 3 of HCV containing substantially all the epitopes of the gene 3 protein. In the preferred embodiment the recombinant 102 amino acid peptide is coated onto a solid support, and incubated in the presence of serum obtained from a patient infected with HCV. The presence of antibodies bound to the antigen coated support is detected in a sandwich format utilizing a second reporter-conjugated antibody.
Abstract:
An assay for antigens of hepatitis C virus utilizes a synthetic peptide comprising the first 38 amino acids of the capsid region containing at least two immunodominant epitopes. The assay detects antibodies in the sera of patients infected with the Non-A Non-B hepatitis virus. Of particular efficacy is a competitive inhibition assay, which incorporates in the liquid phase an inhibitor consisting of a peptide containing only one of the immunodominant capsid epitopes, which is capable of inhibiting binding of antibodies to all target epitopes present on the solid substrate.
Abstract:
This invention provides a novel process of producing magnetically responsive polymer particles comprising polymeric core particles coated evenly with a layer of polymer containing magnetically responsive metal oxide. A wide variety of polymeric particles with sizes ranging from 1 to 100 microns can be used as core particles and transformed into magnetically responsive polymer particles. The surface of these magnetically responsive polymer particles can be coated further with another layer of functionalized polymer. These magnetically responsive polymer particles can be used for passive or covalent coupling of biological material such as antigens, antibodies, enzymes or DNA/RNA hybridization and used as solid phase for various types of immunoassays, DNA/RNA hybridization probes assays, affinity purification, cell separation and other medical, diagnostic, and industrial applications.
Abstract:
A chromogenic assay for determination of blood coagulation Factor VIII:Ca, using an indicator of Factor Xa simultaneously as a mesure of Factor VIII:Ca concentration and as an inhibitor of Factor Xa. This technique can be applied to measure the concentration of an activating enzyme using the rate of conversion of the indicator molecule of the product of that enzyme as an indirect indicator of enzyme concentration.